CF
TNYA icon

Corebridge Financial’s Tenaya Therapeutics TNYA Stock Holding History

Corebridge Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,022
Closed -$15.4K – 2556
2025
Q1 		$15.4K Sell
27,022
-401
-1% -$396 ﹤0.01% 2937
2024
Q4 		$39.2K Sell
27,423
-2,070
-7% -$4.64K ﹤0.01% 2882
2024
Q3 		$56.9K Sell
29,493
-182
-0.6% -$514 ﹤0.01% 2842
2024
Q2 		$92K Buy
+29,675
New +$123K ﹤0.01% 2639

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Corebridge Financial's TNYA Position: Q2 2025 in Review

Corebridge Financial sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 27,022 shares — an estimated $15.4K sold.

Corebridge Financial first reported a position in TNYA in Q2 2024 and held it in 4 quarters. The position peaked at $92K in Q2 2024. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Corebridge Financial reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 27,022 Tenaya Therapeutics shares in Q2 2025, an estimated $15.4K.
  • Corebridge Financial first reported a position in Tenaya Therapeutics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Tenaya Therapeutics position peaked at $92K in Q2 2024.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.